Susquehanna International Group’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.62M | Sell |
750,393
-774,170
| -51% | -$2.79M | ﹤0.01% | 5561 |
|
|
2025
Q4 | $5.21M | Buy |
1,524,563
+106,030
| +7% | +$473K | 0.01% | 3946 |
|
|
2025
Q3 | $7.14M | Buy |
1,418,533
+824,245
| +139% | +$3.63M | 0.01% | 3531 |
|
|
2025
Q2 | $2.04M | Buy |
594,288
+345,643
| +139% | +$860K | ﹤0.01% | 5739 |
|
|
2025
Q1 | $554K | Sell |
248,645
-168,751
| -40% | -$484K | ﹤0.01% | 8672 |
|
|
2024
Q4 | $1.22M | Buy |
417,396
+183,332
| +78% | +$511K | ﹤0.01% | 6469 |
|
|
2024
Q3 | $609K | Sell |
234,064
-14,684
| -6% | -$40.7K | ﹤0.01% | 7990 |
|
|
2024
Q2 | $736K | Buy |
248,748
+26,690
| +12% | +$101K | ﹤0.01% | 7303 |
|
|
2024
Q1 | $1.01M | Sell |
222,058
-113,934
| -34% | -$581K | ﹤0.01% | 6908 |
|
|
2023
Q4 | $1.92M | Buy |
335,992
+95,767
| +40% | +$444K | ﹤0.01% | 5449 |
|
|
2023
Q3 | $1.11M | Sell |
240,225
-298,781
| -55% | -$1.82M | ﹤0.01% | 6414 |
|
|
2023
Q2 | $3.48M | Buy |
539,006
+385,667
| +252% | +$2.63M | 0.01% | 4121 |
|
|
2023
Q1 | $1.16M | Sell |
153,339
-12,770
| -8% | -$116K | ﹤0.01% | 6433 |
|
|
2022
Q4 | $1.68M | Buy |
166,109
+106,065
| +177% | +$1.23M | ﹤0.01% | 5044 |
|
|
2022
Q3 | $594K | Buy |
+60,044
| New | +$659K | ﹤0.01% | 8023 |
|
|
2022
Q2 | – | Sell |
-128,512
| Closed | -$1.09M | – | 12758 |
|
|
2022
Q1 | $1.25M | Sell |
128,512
-285,901
| -69% | -$2.71M | ﹤0.01% | 6574 |
|
|
2021
Q4 | $5.93M | Sell |
414,413
-19,967
| -5% | -$303K | 0.01% | 3471 |
|
|
2021
Q3 | $8.71M | Buy |
434,380
+201,554
| +87% | +$3.56M | 0.01% | 3072 |
|
|
2021
Q2 | $5.12M | Buy |
232,826
+162,626
| +232% | +$4.48M | 0.01% | 3993 |
|
|
2021
Q1 | $2.38M | Buy |
70,200
+49,105
| +233% | +$1.96M | ﹤0.01% | 5488 |
|
|
2020
Q4 | $849K | Buy |
+21,095
| New | +$965K | ﹤0.01% | 7086 |
|
Other funds holding ABCL
BBA
TWC
ACH
DCM
